Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the healthcare industry. This time, you get to discover 5 hand-picked startups developing oncology decision support systems.
Out of 589, the Global Startup Heat Map highlights 5 Top Oncology Decision Support Systems Startups
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 589 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 healthcare startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 584 oncology decision support systems solutions, get in touch.
Metadvice enables Clinical Data Analysis
Founding Year: 2018
Location: London, UK
Partner for Precision Medicine Engines
British startup Metadvice develops an AI-based clinical intelligence platform for physicians. The startup’s proprietary technology distills complex medical insights from diagnostic test data, patient records, disease-specific information, relevant literature, and case studies to offer recommendations for diagnosis and therapy. Its precision medicine engine maps the latest standard clinical practice guidelines and facilitates evidence-based clinical decisions for the treatment of hematological cancers. Moreover, it uses distributed ledger technology (DLT) to encrypt and anonymize patient data, thereby ensuring safety and compliance.
Neosoma offers a Neuro-Oncology AI Platform
Founding Year: 2019
Location: Boston, USA
Funding: USD 75 000
Partner for 3D Tumor Analysis
US-based startup Neosoma offers a proprietary software-as-a-service (SaaS) platform for neuro-oncology assessment. It uses AI to analyze magnetic resonance imaging (MRI) brain scans to extract hidden insights for diagnosis and care. The software explores tumors in 3D to provide longitudinal disease assessment, centralized document management, clinical notes storage, and virtual tumor board sessions. The platform facilitates centralized decision-making and patient management among multiple oncologists and integrates with existing hospital digital infrastructure.
Nucleai provides Tissue Biopsy Analysis
Founding Year: 2017
Location: Tel Aviv, Israel
Partner for Tissue Diagnostic Biopsies
Israeli startup Nucleai offers image analysis software to aid in pathological analysis. The startup’s AI-based image analysis platform, Nuclei Atom, analyzes pathology slides to detect cancerous tissues. It has access to millions of annotated images to compare with to decipher 12 major cancer types. It enables incidental findings and limits errors in diagnosis. By allowing physicians to detect spatial biomarkers, Nuclei Atom supports treatment decisions and predicts response to therapy. These biomarkers also aid in identifying genomic makers to decipher complex biological mechanisms involved in cancer progression.
Onkolyze offers Ultrasound Analysis
Founding Year: 2018
Partner for Personalized Diagnosis & Treatment for Breast Cancer
Singaporean startup Onkolyze provides AI-powered software to analyze ultrasound scans. It uses computer vision algorithms to detect, segment, and classify ultrasound images and enable breast cancer detection. The Onkolyze platform integrates ultrasound scan data with other clinical data of patients to simulate clinical outcomes. This enables physicians to provide personalized cancer diagnosis and treatment for their patients. The multiple data modality simulations and AI-driven tool kit to scrutinize millions of treatment strategies further allow physicians to make decisions using in-silico treatment modeling. The process benefits patients since both the treatment and dosages are precise, unlike in conventional treatment practices.
ARTIDIS delivers Metastasis Prediction
Founding Year: 2017
Location: Basel, Switzerland
Funding: USD 9,5 M
Partner for Nanomechanical Sensor & AI-powered Algorithms
German startup ARTIDIS develops a proprietary platform for metastasis prediction. It uses a nanomechanical sensor that differentiates between benign and malignant tissue. ARTIDISNET, the startup’s AI-powered platform, integrates nanomechanical biomarkers and clinical data to facilitate personalized treatment. The startup’s solution analyzes the biopsy samples to prioritize diagnoses. The ARTIDISNET platform further combines diagnostic image data, genetic data, histopathology, therapy, and more to generate valuable insights.
Discover more Healthcare Startups
Healthcare startups such as the examples highlighted in this report focus on AI-driven decision support tools, neurodegeneration, as well as data analytics for diagnostics. While all of these technologies play a major role in advancing the healthcare industry, they only represent the tip of the iceberg. To explore more healthcare technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free Healthcare Innovation Report to save your time and improve strategic decision-making.